Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy

Edward Laane, Katja Pokrovskaja Tamm, Eva Buentke, +15

Cell Death and Differentiation

Cell AutophagyMitophagyLymphoid LeukemiaMalignant Blood DisorderApoptosis +9

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Ulf‐Henrik Mellqvist, Peter Gimsing, Øyvind Hjertner, +22

Blood

Doxorubicin Requires the Sequential Activation of Caspase-2, Protein Kinase Cδ, and c-Jun NH₂-terminal Kinase to Induce Apoptosis

Theocharis Panaretakis, Edward Laane, Katja Pokrovskaja Tamm, +6

Molecular Biology of the Cell

ApoptosisImmunologyCell DeathPathologyImmunologic Mechanism +17

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos, +273

Clinical Lymphoma Myeloma & Leukemia

Investigation and management of IgM and Waldenström‐associated peripheral neuropathies: recommendations from the <scp>IWWM</scp> ‐8 consensus panel

Shirley D’Sa, Marie José Kersten, Jorge J. Castillo, +8

British Journal of Haematology

Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies

Dan Grandér, Pedram Kharaziha, Edward Laane, +2

Autophagy

MitophagyApoptosisImmunologyBlood CellCell Death +18

Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members

Edward Laane, Theocharis Panaretakis, Eva Buentke, +7

Haematologica

Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma

Edward Laane, Edneia Tani, Elisabet Björklund, +4

Cytometry Part B Clinical Cytometry

The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy.

Edward Laane, Åsa Rangert Derolf, Elisabet Björklund, +5

PubMed

Mixed-phenotype Acute LeukemiaImmunologyPathologyMyeloid NeoplasiaHematological Malignancy +14

Sorafenib Has Potent Antitumor Activity against Multiple Myeloma <i>In Vitro</i> , <i>Ex Vivo</i> , and <i>In Vivo</i> in the 5T33MM Mouse Model

Pedram Kharaziha, Hendrik De Raeve, Charlotte Fristedt, +14

Cancer Research